Live Breaking News & Updates on American Society Of Clinical Oncology Meeting

Stay updated with breaking news from American society of clinical oncology meeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Race Associated With Kidney Cancer Survival Disparities

Across disease stages, Black patients with renal cell carcinoma experience worse survival outcomes than White patients, research has shown. ....

United-states , American , American-society-of-clinical-oncology-meeting , National-cancer-database , Kidney-cancer-program-at-johns-hopkins-medicine , Urologic-oncology , Original-investigations , Possible-treatment-identified , Rare-kidney-cancer , Nirmish-singla , Kidney-cancer-program

Verastem Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progre

Presented Positive Results from Part A of RAMP 201 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) at American Society of Clinical Oncology MeetingEstablished Design for RAMP 301 Phase 3 Confirmatory Trial of Avutometinib and Defactinib in Recurrent LGSOCStrengthened Balance. ....

United-states , American , Dan-calkins , Karin-tollefson , Dan-paterson , Robert-gagnon , Brian-stuglik , Elisa-buffington , Nate-liabraaten , Company-board-of-directors , Raf-and-mek-program , Commercialization-committee

ctDNA negative status contributes to positive outcomes for DLBCL

ctDNA negative status contributes to positive outcomes for DLBCL
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states , Chicago , Illinois , American , Bristol-myers-squibb , Genentech-roche , Katrina-altersitz , Adicet-bio , Bycory-perla , Astrazeneca-medimmune , Alex-herrera , Tubulis-gmb

Cabometyx Plus Opdivo, Yervoy Boosts Advanced Kidney Cancer Outcomes

Adding Cabometyx to Opdivo and Yervoy tended to improve progression-free survival in patients with advanced kidney cancer, research showed. ....

United-states , American , American-society-of-clinical-oncology-meeting , New-england-journal , Clinical-oncology-meeting ,

Adding Jemperli to Chemo Lengthens Time to Progression in Early Endometrial Cancer

Jemperli plus carboplatin and paclitaxel also helped patients with early endometrial cancer maintain their health-related quality of life throughout follow-up. ....

Denmark , United-states , Copenhagen , Køavn , American , Mansoor-raza-mirza , American-society-of-clinical-oncology-meeting , Copenhagen-university-hospital , Adding-jemperli , Clinical-oncology , Endometrial-cancer , Asco-annual-meeting